Prime Minister Keir Starmer said weight-loss drugs like Novo Nordisk’s Ozempic and Eli Lilly and Co’s Mounjaro could help improve the UK economy and lift pressures on the country’s beleaguered National Health Service,

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy. Health minister Wes Streeting predicted the use of the drug - a competitor to Novo Nordisk's Ozempic - could help transform the health of the nation,

Weight-loss jabs ‘important for economy so people get back into work’, says PM - Sir Keir Starmer said anti-obesity medication could help boost Britain’s economy.

New weight loss jabs could be given to unemployed people to help them get back into work, Sir Keir Starmer has said. The Prime Minister said that the drugs would be “very important” for reducing obesity rates and helping to reduce the burden on the NHS.

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy.